Outcome of Board Meeting
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2015, inter alia, has discussed and approved the following items :1. Resignation of Mr. Venkat RadhakrishnanMr. Venkat Radhakrishnan being a non-resident Indian is unable to involve in the activities of the Company and to attend the Board Meetings. He had expressed his desire to step down as an Independent Director.... Financial Results & Limited Review for March 31, 2015 (Standalone)
Caplin Point Laboratories Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended March 31, 2015. Appointment of CFO
Caplin Point Laboratories Ltd has informed BSE that Mr. P Harihara Ponnambalam is appointed as Chief Financial Officer by the Board of the Company with effect from May 06, 2015. Closure of Trading Window
Caplin Point Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 12, 2015, inter alia, to consider, approve and take on record the Un-Audited Financial Results of the Company for the Quarter ended March 31, 2015.Further, the trading window will be closed from May 08, 2015 to May 12, 2015 (both days inclusive) in connection with the approval of the Un-Audited financial results... Shareholding Pattern For March 31, 2015
Caplin Point Laboratories Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015. Appointment of Company Secretary and Compliance Officer
Caplin Point Laboratories Ltd has informed BSE that Mr. Vinod Kumar Srinivasan is appointed as Company Secretary and Compliance Officer by the Board of the Company with effect from April 13, 2015. Caplin Point Laboratories
Caplin Point Laboratories has entered into a license and distribution agreement with Cycle Pharmaceuticals Ltd, a UK-based company. According to the terms of the agreement, Caplin Point will... Updates
Caplin Point Laboratories Ltd has informed BSE that:A license and distribution agreement has been made and entered by and between Caplin Point Laboratories Limited, India and Cycle Pharmaceuticals Limited, a Limited Company having its principal offices at Cambridge, UK.Cycle Pharmaceuticals Limited is one of the niche global pharmaceutical companies with unique products and sharp focus on key geographies like USA and Europe.... Updates
Caplin Point Laboratories Ltd has informed BSE that a license and distribution agreement has been made and entered by and between Caplin Point Laboratories Limited, India and Fresenius Kabi USA, LLC, a Delaware Limited Liability Company.Fresenius Kabi is one of the leading global pharmaceutical companies with unique products and sharp focus on key geographies like USA and Europe.... Updates
Caplin Point Laboratories Ltd has informed BSE that in connection with the approval of the Company's state of art sterile injectable facility (Unit IV) under European GMP, the Officials of EU GMP had carried out inspection of the unit recently. The outcome of the inspection is very positive and it is likely that the approval may be accorded shortly. The Company shall update upon receipt of the final communication from the said Authorities.